Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 15, 2018 08:00 ET | Source: Quotient Limited

Quotient Limited to Report Fourth Quarter and Fiscal Full Year 2018 Financial Results and Host Conference Call

JERSEY, Channel Islands, May 15, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fourth quarter and...
March 26, 2018 16:15 ET | Source: Quotient Limited

Quotient Limited Reports Blood Grouping Concordance Data From MosaiQ Verification and Validation Studies and Updates on the Completion of Its Sale Leaseback Transaction

Verification & Validation (“V&V”) “head-to-head” data exceeds target concordance for blood groupingOverall concordance for antigen typing – 99.8%, demonstrating robustness of the MosaiQ...
March 26, 2018 16:05 ET | Source: Quotient Limited

Quotient Limited Announces Retirement of Paul Cowan, Chairman and Chief Executive Officer; Franz Walt Named as Interim Chief Executive Officer

JERSEY, Channel Islands, March 26, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the retirement of Paul Cowan as its Chairman and...
March 01, 2018 16:05 ET | Source: Quotient Limited

Quotient Limited to Participate in the Cowen 38th Annual Global Health Care Conference

JERSEY, Channel Islands, March 01, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...
February 20, 2018 16:05 ET | Source: Quotient Limited

Quotient Limited Announces the Sale and Leaseback of its Edinburgh, Scotland Manufacturing and R&D Facility

JERSEY, Channel Islands, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced it has entered into definitive agreements for the...
February 20, 2018 08:00 ET | Source: Quotient Limited

Quotient Limited Announces Appointment of Franz Walt as Non-Executive Director

JERSEY, Channel Islands, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Franz Walt to its board of...
February 05, 2018 16:05 ET | Source: Quotient Limited

Quotient Limited Updates on Status of MosaiQ Performance and Provides Third Quarter Fiscal 2018 Financial Results

Manufacturing process change implemented with improved assay performance Verification and Validation (V&V) studies for blood grouping to resumeMosaiQ SDS Microarray preparing to enter into formal...
January 31, 2018 08:00 ET | Source: Quotient Limited

Quotient Limited to Participate in the LEERINK Partners 7th Annual Global Healthcare Conference

JERSEY, Channel Islands, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...
January 23, 2018 08:00 ET | Source: Quotient Limited

Quotient Limited to Report Fiscal Third Quarter 2018 Financial Results and Host Conference Call

JERSEY, Channel Islands, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal third quarter...
January 08, 2018 20:15 ET | Source: Quotient Limited

Quotient Limited Reports Further Positive Data on its Initial Disease Screening Microarray and Provides Update on Blood Grouping

Performance evaluation studies for the initial disease screening microarray demonstrate 100% sensitivity and >99% specificity for the CMV and Syphilis assaysV&V for blood grouping is ongoing –...